SMA HCP Roundup, mid-February: X-linked infantile SMA, Risdiplam News & More

SMA HCP Roundup, mid-February: X-linked infantile SMA, Risdiplam News & More

Research on SMA continues to forge ahead in 2020, with new results in from Roche’s latest investigation into its oral SMA drug, risdiplam. New tools for screening are being revealed as legislative changes are pushing more and more toward requiring infants born in the...
SMA HCP News December Round-up: Spinal Cord Hypoxia, Scoliosis Surgery & More

SMA HCP News December Round-up: Spinal Cord Hypoxia, Scoliosis Surgery & More

Regulators continue to review SMA drugs and consider policies related to newborn screening while new data emerge related to the mechanisms underlying the disease, as well as those concerning management and treatment.  Here is a roundup of some of the latest news and...